Skip to content
healthcare.dev

Cytarabine

NDC 71288-169, Cytarabine, injection, solution, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-169
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208485
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-169 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYTARABINE20 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
71288-169-25712880169251 VIAL, MULTI-DOSE in 1 CARTON (71288-169-25) / 25 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8b366382-c8d1-4344-86b7-f65e92a8952b

Use it

Look up 71288-169 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-169 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-169. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.